How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans in Resectable NSCLC



Published
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans in Resectable NSCLC

Co-Chairs, Nasser Altorki, MD, and Jonathan D. Spicer, MD, PhD, FRCSC, discuss NSCLC in this CME/MOC activity titled “How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans to Improve Outcomes in Resectable NSCLC.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/GWF865. CME/MOC credit will be available until June 14, 2023.
Category
Health
Be the first to comment